Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE2
Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia
- Status
- UNKNOWN
- Phase
- N/A
CLL Therapy Approaches in Russia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia
- Status
- COMPLETED
- Phase
- NA
Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A
B-cell Chronic Lymphoid Malignancies Markers
- Status
- UNKNOWN
- Phase
- N/A
Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
MEOI and HRQoL in CLL Patients Treated With BTKis
- Status
- COMPLETED
- Phase
- N/A